lobbying_activities: 3015908
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3015908 | f07f0800-dc3b-473e-b03f-81622c91c78d | Q2 | REM STRATEGIES, LLC | 401104903 | A.P. GOLDSHIELD LLC | 2023 | second_quarter | CHM | Discussion with EPA and FDA about label claims for Goldshield antimicrobial technologies. | Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2023-07-19T13:51:07-04:00 |